Alkem Laboratories Annual Report 2024-25 | Pharma

Alkem Laboratories' 2024-25 annual report details the pharmaceutical company's strategic initiatives across generics, biosimilars, and MedTech divisions. The report highlights portfolio expansion, global growth, supply chain resilience, and commitment to equitable healthcare access while maintaining focus on quality and compliance.